ebook Munafa Stock Market Course + Intraday & FNO calls  

       

506235 announcements Alembic Ltd. announcements and dividends declared BSE

Alembic Ltd. Complete list of announcements declared & dividend announcements by Alembic Ltd. 506235

Alembic Ltd. 506235 listed on BSE and deals in

Announcements and dividends declared by Alembic Ltd. 506235

Alembic Pharmaceuticals gets USFDA nod for generic Carbamazepine tablets
Alembic Pharmaceuticals has received final approval from the USFDA for its generic Carbamazepine extended-release tablets (100 mg, 200 mg, and 400 mg), used to treat seizures and nerve pain. The product is a generic version of Novartis’ Tegretol-XR. Acco
Announcement as on 28 July 2025

Alembic Pharmaceuticals gets USFDA nod for generic cancer treatment injection
Alembic Pharmaceuticals has received final USFDA approval. This approval is for its generic Doxorubicin Hydrochloride Liposome injection. The injection comes in strengths of 20 mg/10 mL and 50 mg/25 mL. It is used to treat ovarian cancer, AIDS-Related Kapo
Announcement as on 30 June 2025

Alembic Pharma gets USFDA nod for generic high blood pressure treatment drug
Alembic Pharmaceuticals announced that it has secured final approval from the USFDA for its generic amlodipine and atorvastatin tablets, used for treating hypertension. The approval covers multiple strengths of the tablets, therapeutically equivalent to Ph
Announcement as on 23 May 2025

Alembic gets USFDA nod for generic drug
Alembic Pharmaceuticals secured USFDA approval to market generic Ticagrelor tablets, 90 mg, aimed at preventing heart attack and stroke. They also received tentative approval for the 60 mg version. The approved drug is equivalent to AstraZeneca's Brilinta,
Announcement as on 02 May 2025

Alembic Pharma gets USFDA nod for generic drug
Alembic Pharmaceuticals has received the United States Food and Drug Administration approval. The approval allows them to market Carbamazepine tablets in the US. This medication is a generic version of Tegretol Tablets. Carbamazepine tablets are anticonvul
Announcement as on 17 April 2025

Announcements by Alembic Ltd. first page | Next page | Prev page |

506235 Alembic Ltd. current price & indicator signals

Moving Averages for Alembic Ltd.

  • 5Day Average: 88.15
  • 12Day Average: 90.44
  • 20Day Average: 91.1
  • 50Day Average: 86.27
  • 100Day Average: 90.93
  • 150Day Average: 94.02
  • 200Day Average: 96.9

506235 Indicators & signals

Indicator MACD (12,26,9)

89.49, 89.52, 0.81
Indicator MACD is in negative zone

Indicator ADX (14)

15.52, 19.44, 26.59
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 52
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 506235 Alembic Ltd. are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
22 Fri May 2026 87.46 87.11 to 88.85 0.09% 0.69 times
21 Thu May 2026 87.38 87.00 to 89.20 -0.13% 0.77 times
20 Wed May 2026 87.49 86.80 to 88.51 -2.75% 0.72 times
19 Tue May 2026 89.96 88.00 to 91.00 1.67% 1.15 times
18 Mon May 2026 88.48 86.88 to 90.38 -1.49% 0.58 times
15 Fri May 2026 89.82 89.70 to 92.00 -1.75% 0.93 times
14 Thu May 2026 91.42 90.00 to 91.74 1.6% 0.67 times
13 Wed May 2026 89.98 89.06 to 90.70 -0.48% 1.08 times
12 Tue May 2026 90.41 90.05 to 92.84 -2.28% 1.24 times
11 Mon May 2026 92.52 92.00 to 93.93 -2.55% 2.01 times
08 Fri May 2026 94.94 94.43 to 95.33 -0.48% 0.85 times
07 Thu May 2026 95.40 92.61 to 96.24 2.44% 4.2 times

Videos related to: 506235 announcements Alembic Ltd. announcements and dividends declared BSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

506235 announcements Alembic Ltd. announcements and dividends declared BSE

 

Back to top